gH625 constitutes a promising delivery vehicle for the transport of therapeutic biomacromolecules across membrane barriers. We report an application of multivalency to create a complex nanosystem for delivery and to elucidate the mechanism of peptide-lipid bilayer interactions. Multivalency may offer a route to enhance gH625 cellular uptake as demonstrated by results obtained on dimers of gH625 by fluorescence spectroscopy, circular dichroism, and surface plasmon resonance. Moreover, using both phase contrast and light sheet fluorescence microscopy we were able to characterize and visualize for the first time the fusion of giant unilamellar vesicles caused by a membranotropic peptide.
Dimerization in tailoring uptake efficacy of the HSV-1 derived membranotropic peptide gH625 / Falanga, Annarita; Valiante, Salvatore; Galdiero, Emilia; Franci, Gianluigi; Scudiero, Olga; Morelli, Giancarlo; Galdiero, Stefania. - In: SCIENTIFIC REPORTS. - ISSN 2045-2322. - 7:1(2017), pp. 9434-9453. [10.1038/s41598-017-09001-x]
Dimerization in tailoring uptake efficacy of the HSV-1 derived membranotropic peptide gH625
FALANGA, ANNARITAPrimo
;VALIANTE, Salvatore;GALDIERO, EMILIA;SCUDIERO, OLGA;MORELLI, GIANCARLO;GALDIERO, STEFANIA
Ultimo
Writing – Review & Editing
2017
Abstract
gH625 constitutes a promising delivery vehicle for the transport of therapeutic biomacromolecules across membrane barriers. We report an application of multivalency to create a complex nanosystem for delivery and to elucidate the mechanism of peptide-lipid bilayer interactions. Multivalency may offer a route to enhance gH625 cellular uptake as demonstrated by results obtained on dimers of gH625 by fluorescence spectroscopy, circular dichroism, and surface plasmon resonance. Moreover, using both phase contrast and light sheet fluorescence microscopy we were able to characterize and visualize for the first time the fusion of giant unilamellar vesicles caused by a membranotropic peptide.File | Dimensione | Formato | |
---|---|---|---|
41598_2017_Article_9001.pdf
solo utenti autorizzati
Tipologia:
Documento in Post-print
Licenza:
Creative commons
Dimensione
2.72 MB
Formato
Adobe PDF
|
2.72 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.